 Connection
Lisa Bero to Advisory Committees
This is a "connection" page, showing publications Lisa Bero has written about Advisory Committees.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.781 |
|
|
|
-
Nguyen NT, Cook DM, Bero LA. The decision-making process of US Food and Drug Administration advisory committees on switches from prescription to over-the-counter status: a comparative case study. Clin Ther. 2006 Aug; 28(8):1231-1243.
Score: 0.256
-
Nejstgaard CH, Bero L, Hr?bjartsson A, J?rgensen AW, J?rgensen KJ, Le M, Lundh A. Association between conflicts of interest and favourable recommendations in clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews: systematic review. BMJ. 2020 12 09; 371:m4234.
Score: 0.173
-
Nejstgaard CH, Bero L, Hr?bjartsson A, J?rgensen AW, J?rgensen KJ, Le M, Lundh A. Conflicts of interest in clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews: associations with recommendations. Cochrane Database Syst Rev. 2020 12 08; 12:MR000040.
Score: 0.173
-
Smith R, Tovey D, Bero L, Busuttil G, Farquhar C, Koehlmoos TP, Moher D, Nylenna M, Pais P. The Cochrane Library Oversight Committee. Cochrane Database Syst Rev. 2011 Feb 16; (8):ED000021.
Score: 0.088
-
Cook DM, Gurugubelli RK, Bero LA. Risk management policy and black-box warnings: a qualitative analysis of US FDA proceedings. Drug Saf. 2009; 32(11):1057-66.
Score: 0.076
-
Steinman MA, Bero LA, Chren MM, Landefeld CS. Narrative review: the promotion of gabapentin: an analysis of internal industry documents. Ann Intern Med. 2006 Aug 15; 145(4):284-93.
Score: 0.016
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|